SL
Siren LLC Portfolio holdings
AUM
$1.93B
1-Year Return
118.08%
This Quarter Return
+18.65%
1 Year Return
+118.08%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.93B
AUM Growth
+$160M
(+9%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
48.49%
Holding
131
New
15
Increased
21
Reduced
19
Closed
21
Top Buys
| 1 |
MoonLake Immunotherapeutics
MLTX
|
$24M |
| 2 |
Dyne Therapeutics
DYN
|
$20.2M |
| 3 |
Edgewise Therapeutics
EWTX
|
$19.2M |
| 4 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$18.1M |
| 5 |
Akero Therapeutics
AKRO
|
$17M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$64.3M |
| 2 |
Soleno Therapeutics
SLNO
|
$21.8M |
| 3 |
Prothena Corp
PRTA
|
$15.9M |
| 4 |
Summit Therapeutics
SMMT
|
$13.4M |
| 5 |
NewAmsterdam Pharma
NAMS
|
$13M |
Sector Composition
| 1 | Healthcare | 90.42% |
| 2 | Technology | 4.93% |
| 3 | Communication Services | 2.51% |
| 4 | Consumer Discretionary | 1.07% |
| 5 | Real Estate | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Neumora Therapeutics
NMRA
$264M
| $3.2M | 0.17% |
4,358,283
| – | – |
|
77
ProQR Therapeutics
PRQR
$252M
| $3.17M | 0.16% |
1,552,183
| – | – |
|
|
NBIS
78
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.5B
| $2.82M | 0.15% |
51,000
-89,000
| -64% | -$4.92M |
|
79
Black Diamond Therapeutics
BDTX
$163M
| $2.6M | 0.13% |
1,046,517
| – | – |
|
80
Lexeo Therapeutics
LXEO
$268M
| $2.43M | 0.13% |
603,435
| – | – |
|
81
Palo Alto Networks
PANW
$129B
| $2.35M | 0.12% |
11,500
| – | – |
|
82
Qualcomm
QCOM
$172B
| $2.23M | 0.12% |
14,000
| – | – |
|
83
Workiva
WK
$4.26B
| $1.92M | 0.1% |
28,000
+10,500
| +60% | +$719K |
|
84
Eledon Pharmaceuticals
ELDN
$156M
| $1.87M | 0.1% |
690,170
| – | – |
|
85
KE Holdings
BEKE
$21.9B
| $1.86M | 0.1% |
105,000
| – | – |
|
86
HubSpot
HUBS
$24.5B
| $1.67M | 0.09% |
+3,000
| New | +$1.67M |
|
87
UnitedHealth
UNH
$281B
| $1.58M | 0.08% |
+5,076
| New | +$1.58M |
|
|
BIOA
88
BioAge Labs, Inc. Common Stock
BIOA
$169M
| $1.58M | 0.08% |
382,406
| – | – |
|
89
GitLab
GTLB
$7.18B
| $1.58M | 0.08% |
+35,000
| New | +$1.58M |
|
90
Tourmaline Bio
TRML
$645M
| $1.46M | 0.08% |
91,426
| – | – |
|
91
Rocket Pharmaceuticals
RCKT
$349M
| $1.45M | 0.08% |
591,263
| – | – |
|
92
Tesla
TSLA
$1.09T
| $1.27M | 0.07% |
4,000
-5,000
| -56% | -$1.59M |
|
93
Birkenstock
BIRK
$9.31B
| $1.23M | 0.06% |
+25,000
| New | +$1.23M |
|
|
SAIL
94
SailPoint, Inc. Common Stock
SAIL
$11.7B
| $1.14M | 0.06% |
50,000
-45,000
| -47% | -$1.03M |
|
95
Semrush
SEMR
$1.14B
| $1.13M | 0.06% |
125,000
| – | – |
|
|
PRMB
96
Primo Brands Corporation
PRMB
$9.38B
| $1.11M | 0.06% |
+37,500
| New | +$1.11M |
|
97
Cellebrite
CLBT
$4B
| $960K | 0.05% |
+60,000
| New | +$960K |
|
98
Generation Bio
GBIO
$38.9M
| $950K | 0.05% |
296,893
| – | – |
|
|
KLRS
99
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.2M
| $755K | 0.04% |
282,586
| – | – |
|
|
HOOK
100
DELISTED
HOOKIPA Pharma
HOOK
| $711K | 0.04% |
566,640
| – | – |
|